Seattle, Washington
Phase 1 cancer trials in Seattle, WA
90 Phase 1 cancer studies are recruiting participants at sites in Seattle as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Seattle at a glance
- 90 studies are recruiting at a site in Seattle.
- By phase: Phase 1 (48), Phase 1/2 (42).
- By sponsor: industry (78), university, hospital or other (12).
- By research area: Breast Cancer (24), Lung Cancer (24), Lymphoma (24), Prostate Cancer (11), Pancreatic Cancer (6), Melanoma (1).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Seattle
Basic details from each study's public record (the 30 most recently updated of 90). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Phase 1/2 Study of IAM1363 in HER2 Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Iambic Therapeutics, Inc
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06253871 · updated
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT06324357 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07488676 · updated
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Phase 1/2
- All ages
- All sexes
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT06590857 · updated
An Investigational Study of BG-75202 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- BeOne Medicines
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT07222267 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Seattle, WA on ClinicalTrials.gov.
Lung cancer studies recruiting in Seattle
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT05786924 · updated
A Study of VET3-TGI in Patients With Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- KaliVir Immunotherapeutics
- Study site
- University of Washington, Fred Hutchinson Cancer Center
- Registry record
- NCT06444815 · updated
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study site
- Swedish Cancer Institute
- Registry record
- NCT07277413 · updated
Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Boehringer Ingelheim
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT04886804 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- University of Washington/Fred Hutchinson Cancer Center
- Registry record
- NCT07080242 · updated
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Verastem, Inc.
- Study site
- Virginia Mason Medical Center
- Registry record
- NCT07020221 · updated
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BlossomHill Therapeutics
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT06706076 · updated
T Cell Receptor T Cells for Advanced KRAS G12V-mutant Non-small Cell Lung Cancer, Pancreas Cancer, Colon Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Fred Hutchinson Cancer Center
- Study site
- Fred Hutch/University of Washington Cancer Consortium
- Registry record
- NCT06043713 · updated
A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT07564401 · updated
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Avenzo Therapeutics, Inc.
- Study site
- Avenzo Therapeutics Recruiting Site
- Registry record
- NCT07038343 · updated
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Moonlight Bio, Inc
- Study site
- Fred Hutch Cancer Center
- Registry record
- NCT07488923 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Seattle, WA on ClinicalTrials.gov.
Prostate cancer studies recruiting in Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT05997615 · updated
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Amgen
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT04221542 · updated
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Swedish Medical Center
- Registry record
- NCT06095089 · updated
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT07082920 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Seattle, WA on ClinicalTrials.gov.
Lymphoma studies recruiting in Seattle
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Seattle Children's Hospital
- Registry record
- NCT04726241 · updated
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Debiopharm International SA
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT05765812 · updated
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- Phase 1
- Ages 0 to 18
- All sexes
- Sponsor
- Autolus Limited
- Study site
- Seattle Children's Hospital
- Registry record
- NCT06173518 · updated
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- PeproMene Bio, Inc.
- Study site
- Providence Swedish Cancer Institute
- Registry record
- NCT05370430 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- Fred Hutchinson Cancer Center
- Registry record
- NCT05384626 · updated
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- Swedish Cancer Institute (SCI)
- Registry record
- NCT07101328 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance)
- Registry record
- NCT07226843 · updated
A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- BeOne Medicines
- Study site
- Fred Hutchinson Cancer Research Center
- Registry record
- NCT06697184 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Seattle, WA on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Seattle
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- University of Washington
- Study site
- Fred Hutch/University of Washington Cancer Consortium
- Registry record
- NCT07645651 · updated
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Artios Pharma Ltd
- Study site
- Fred Hutchinson Cancer Center / University of Washington
- Registry record
- NCT04657068 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Seattle, WA on ClinicalTrials.gov.
Ask about studies near Seattle
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections